Futura Medical (GB:FUM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Futura Medical PLC, a company trading on the AIM market under the ticker FUM and specializing in innovative sexual health products, announced its total issued share capital stands at 302,403,003 Ordinary Shares, with the same number of voting rights as no shares are held in treasury. The company highlighted its lead product Eroxon, a unique topical gel for treating Erectile Dysfunction that works in ten minutes and is available over the counter. They also boast of strategic distribution partnerships across major consumer markets, including the US and Europe.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
